-
June 17, 2013
Astellas Pharma Inc. announced the approval of Prograf in Japan for an additional indication
-
June 12, 2013
AVEO Pharmaceuticals, Inc. and Astellas Pharma, Inc. received a complete response letter for tivozanib from the US FDA.
-
February 13, 2013
AVEO Pharmaceuticals, Inc. (AVEO) and Astellas Pharma, Inc. (ALPMY) recently announced final overall survival (OS) ...
-
February 08, 2013
Vical Inc. (VICL) suffered a net loss per share of 9 cents in the fourth quarter of 2012, narrower than the Zacks ...
-
February 07, 2013
Medivation, Inc. (MDVN) recently announced that its partner Astellas Pharma Inc. (ALPMY) reported Xtandi ...
-
January 29, 2013
Seattle Genetics, Inc. (SGEN) recently presented interim results from a phase I study which is evaluating ASG-5ME ...
-
January 17, 2013
Astellas Pharmaceuticals Inc. (ALPMY) recently announced that the US Food and Drug Administration (FDA) has accepted ...
-
January 15, 2013
Astellas Pharma, Inc. (ALPMY) recently announced the receipt of EU approval for its overactive bladder (OAB) ...
-
January 07, 2013
Entrepreneurial pharmaceutical company, Ironwood Pharmaceuticals, Inc. (IRWD) recently announced that it has ...
-
January 02, 2013
Shares of Infinity Pharmaceuticals (INFI) reached a new 52-week high of $35.32 on December 28, 2012, shortly after ...
-
January 02, 2013
Watson Pharmaceuticals, Inc. (WPI) recently announced that it is seeking FDA approval for its generic version of ...
-
December 31, 2012
We recently reiterated a Neutral recommendation on Medivation, Inc. (MDVN). Medivation received a major boost in ...
-
December 31, 2012
We recently reiterated a Neutral recommendation on United Therapeutics (UTHR). While the company reported strong ...
-
December 28, 2012
Auxilium Pharmaceuticals, Inc. (AUXL) recently announced that the FDA has accepted its supplemental Biologics ...
-
December 27, 2012
Ironwood Pharmaceuticals Inc. (IRWD) recently commenced a phase I study in the US with its anti-anxiety candidate, ...
-
December 12, 2012
Johnson & Johnson's (JNJ) Janssen recently announced that the FDA has granted approval for the label expansion of ...
-
July 19, 2011
Vical gets a small victory with a partnership for its CMV drug.
